The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Importance of Comorbidity in Head and Neck Cancer
Abstract
Objectives/Hypothesis Patients with head and neck cancer are staged according to the morphology of the tumor with little or no attention given to the importance of the other diseases, illnesses, or conditions. These other conditions are generally referred to as comorbidities. Although not a feature of the cancer itself, comorbidity is an important attribute of the patient with cancer. Comorbidity has direct impact on the care of patients, selection of initial treatment, and evaluation of treatment effectiveness. The objective of this thesis is to demonstrate the importance of comorbidity in head and neck cancer. Specifically, the aims are 1) to demonstrate the burden of comorbidity among head and neck cancer patients by comparing the incidence of none, mild, moderate, and severe comorbidity among patients with head and neck cancer to patients with cancers of the colorectum, lung, breast, gynecological sites, or prostate, 2) to demonstrate the independent impact of comorbidity on overall survival, and 3) to demonstrate the importance of comorbidity in the assessment of initial treatment effectiveness. Study Design This was a prospective cohort study of the impact of comorbidity on head and neck cancer patients presenting for treatment between January 1995 and December 1996. Methods In 1994, the author trained cancer registrars at an academic teaching hospital to code comorbidity from the medical record of new patients using a standard comorbidity index. Standard statistical techniques, including multivariable analysis, were used to compare and contrast the burden of comorbidity for patients with different cancers. Life survival techniques and multivariable logistic regression analysis were used to assess the independent prognostic impact of comorbidity. Further, the technique of conjunctive consolidation was used to augment the TNM system with comorbidity information, to more completely assess the impact of different initial treatments for patients with head and neck cancers. Results The cohort consisted of 3,378 patients with cancers of the head and neck (341), colorectum (307), lung (655), breast (483), gynecological sites (482), and prostate (1,110). The percentage of head and neck cancer patients with moderate to severe comorbidity was 21%; this degree of comorbidity burden was second only to patients with lung (40%) and colorectal (25%) cancer. There was a significant relationship between severity of comorbidity and overall survival (log‐rank test, ξ 2 = 15.75;P < .0013). For cancers of the head and neck, lung, breast, and prostate the prognostic significance of comorbidity remained even after controlling for other factors, such as age and TNM stage. Conclusions The results of this study show that comorbidity is an important feature of patients with head and neck cancer. Valid instruments exist to measure and classify the overall severity of comorbidity. The scientific evaluation of treatment and the care of patients are impeded by a rigid adherence to a staging system based solely on morphological descriptions of the cancer while ignoring suitable descriptions of the patient. The author believes that the addition of comorbidity information will improve the value of cancer statistics and the care of cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
International Classification of Diseases for Oncology
National Cancer Institute (2020) · Definitions · doi:10.32388/1bjeus · Cited by 3,805
Boring, C. C., Squires, T. S., Tong, T., & Montgomery, S. (1994) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.44.1.7 · Cited by 1,315
The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer
Satariano, W. A., & Ragland, D. R. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-2-199401150-00002 · Cited by 731
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
Kaplan, M. H., & Feinstein, A. R. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90017-4 · Cited by 670
Greenfield, S., Apolone, G., McNeil, B. J., & Cleary, P. D. (1993) · Medical Care · doi:10.1097/00005650-199302000-00005 · Cited by 493
Using administrative data to describe casemix: A comparison with the medical record
Malenka, D. J., McLerran, D., Roos, N., Fisher, E. S., & E.Wennberg, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90118-x · Cited by 166
Problems of Comorbidity in Mortality After Prostatectomy
Concato, J. (1992) · JAMA · doi:10.1001/jama.1992.03480080047025 · Cited by 152
Newschaffer, C. J., Bush, T. L., & Penberthy, L. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(97)00050-4 · Cited by 145
Cited by
How to measure comorbiditya critical review of available methods
DEGROOT, V, BECKERMAN, H., LANKHORST, G., & BOUTER, L. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(02)00585-1 · Cited by 1,757
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Pfister, D. G., Spencer, S., Adelstein, D., Adkins, D., Anzai, Y., Brizel, D. M., Bruce, J. Y., Busse, P. M., Caudell, J. J., Cmelak, A. J., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0031 · Cited by 1,360
Prognostic Importance of Comorbidity in a Hospital-Based Cancer Registry
Piccirillo, J. F. (2004) · JAMA · doi:10.1001/jama.291.20.2441 · Cited by 1,205
Self-citationThe development of a comorbidity index with physical function as the outcome
GROLL, D., TO, T., BOMBARDIER, C., & WRIGHT, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.018 · Cited by 1,198
Metadata
- Authors
- Piccirillo, J. F.
- Venue
- The Laryngoscope
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 110
- Issue
- 4
- Pages
- 593-602
- ISSN
- 0023-852X (ISSN-L)
- 1531-4995
- OpenAlex
- W2000949271
- Cited by
- 398
- References
- 16
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Importance of Comorbidity in Head and Neck Cancer. https://app.cochat.ai/papers/10.1097/00005537-200004000-00011
- The paper
- Piccirillo, J. F. (2000). Importance of Comorbidity in Head and Neck Cancer. The Laryngoscope. https://doi.org/10.1097/00005537-200004000-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.